UBS has hired Taylor Henricks as its head of mergers and acquisitions in the Americas, as part of its strategy to expand investment banking operations in the U.S.

INmune Bio (NASDAQ:INMB) shares fell another 6% to about $2.17 on Tuesday after brokerages downgraded the stock, saying failure of the company’s experimental Alzheimer’s drug XPro in a mid‑stage trial ...